Proposal of Sinomonas flava gen. nov., sp nov., and description of Sinomonas atrocyanea comb. nov to accommodate Arthrobacter atrocyaneus

A novel actinomycete strain, designated CW 108(T), was isolated from a forest soil in Anhui Province, China. The cells were strictly aerobic, non-motile, bent rods. The strain grew optimally at 30-37 degrees C and pH 6.0-8.0. Chemotaxonomically, the pepti

Genome 10K: A Proposal to Obtain Whole-Genome Sequence for 10 000 Vertebrate Species

The human genome project has been recently complemented by whole-genome assessment sequence of 32 mammals and 24 nonmammalian vertebrate species suitable for comparative genomic analyses. Here we anticipate a precipitous drop in costs and increase in sequ

Satellite formation in drop-on-demand printing of polymer solutions

High speed photographic images of jets formed from dilute solutions of polystyrene in diethyl phthalate ejected from a piezoelectric drop-on-demand inkjet head have been analyzed in order to study the formation and distribution of drops as the ligament collapses. Particular attention has been paid to satellite drops, and their relative separation and sizes. The effect of polymer concentration was investigated. The distribution of nearest-neighbour centre spacing between the drops formed from the ligament is better described by a 2-parameter modified gamma distribution than by a Gaussian distribution. There are (at least) two different populations of satellite size relative to the main drop size formed at normal jetting velocities, with ratios of about three between the diameters of the main drop and the successive satellite sizes. The distribution of the differences in drop size between neighbouring drops is close to Gaussian, with a small non-zero mean for low polymer concentrations, which is associated with the conical shape of the ligament prior to its collapse and the formation of satellites. Higher polymer concentrations result in slower jets for the same driving impulse, and also a tendency to form ligaments with a near-constant width. Under these conditions the mean of the distribution of differences in nearest-neighbour drop size was zero.

TMVA, a novel GPIb-binding protein, significantly prevents platelet microthrombi formation and prolongs discordant cardiac xenograft survival

In xenotransplantation, donor endothelium is the first target of immunological attack. Activation of the endothelial cell by preformed natural antibodies leads to platelet binding via the interaction of the glycoprotein (GP) Ib and von Willebrand factor (vWF). TMVA is a novel GPIb-binding protein purified from the venom of Trimeresurus mucrosquamatus. In this study, the inhibitory effect of TMVA on platelet aggregation in rats and the effect on discordant guinea pig-to-rat cardiac xenograft survival were investigated. Three doses (8, 20 or 40 mug/kg) of TMVA were infused intravenously to 30 rats respectively. Platelet aggregation rate was assayed 0.5, 12, and 24 h after TMVA administration. Wister rats underwent guinea pig cardiac cervical heterotopic transplantation using single dosing of TMVA (20 mug/kg, i.v., 0.5 h before reperfusion). Additionally, levels of TXB2 and 6-keto-PGF(1alpha) within rejected graft tissues were determined by radioimmunoassay. Treatment with TMVA at a dose of 20 or 40 mug/kg resulted in complete inhibition of platelet aggregation 0.5 h after TMVA administration. Rats receiving guinea pig cardiac xenografts after TMVA therapy had significantly prolonged xenograft survival. Histologic and immunopathologic analysis of cardiac xenografts in TMVA treatment group showed no intragraft platelet microthrombi formation and fibrin deposition. Additionally, the ratio of 6-keto-PGF(1alpha) to TXB2 in TMVA treatment group was significantly higher than those in control group. We conclude that the use of this novel GPIb-binding protein was very effective in preventing platelet microthrombi formation and fibrin deposition in a guinea pig-to-rat model and resulted in prolongation of xenograft survival. The increased ratio of PGI(2)/TXA(2) in TMVA treatment group may protect xenografts from the endothelial cell activation and contribute to the prolongation of xenograft survival.